Bayer, One Drop launch AI tool for heart disease prevention

November 4, 2021

Bayer’s two-year-old digital health collaboration with One Drop has borne its first fruit, an artificial intelligence-powered software module for preventing cardiovascular disease (CVD).

The German pharmaceutical company has been working with New York-based One Drop on digital health products that span multiple therapeutic areas, including oncology and women’s health as well as CVD in the alliance, which was expanded last year in a $98 million deal.

Read the source article at pharmaphorum.com
2021-10-27 18:25:49

Share This Story!